Active Biotech (Sweden) Today
| ACTI Stock | SEK 0.09 0.01 10.10% |
PerformanceVery Weak
| Odds Of DistressAbout Average
|
Active Biotech is selling for under 0.0899 as of the 21st of March 2025; that is 10.1 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.089. Active Biotech has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunityinflammatory, and cancer. Active Biotech AB was incorporated in 1982 and is based in Lund, Sweden. Active Biotech operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 264.89 M outstanding shares. More on Active Biotech AB
Moving together with Active Stock
Moving against Active Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Active Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Active Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Active Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors) |
Active Biotech AB (ACTI) is traded on Stockholm Exchange in Sweden and employs 9 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 268.37 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Active Biotech's market, we take the total number of its shares issued and multiply it by Active Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Active Biotech AB operates under Biotechnology sector and is part of Health Care industry. The entity has 264.89 M outstanding shares.
Active Biotech AB has accumulated about 53.13 M in cash with (46.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Active Biotech Probability Of Bankruptcy
Ownership AllocationActive Biotech holds a total of 264.89 Million outstanding shares. Active Biotech AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Active Ownership Details
Active Biotech AB Risk Profiles
Although Active Biotech's alpha and beta are two of the key measurements used to evaluate Active Biotech's performance over the market, the standard measures of volatility play an important role as well.
Active Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Active Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.